Sitagliptin Tablets

Healthy Inc is a specialized global supplier and exporter of advanced “Smart” anti-diabetic agents. We provide high-purity Sitagliptin Phosphate Tablets, sourced from WHO–GMP certified solid dosage facilities. This “Glucose-Dependent” insulin booster is a top export to diabetic clinics, premium pharmacy chains, and private healthcare networks in Africa, LATAM, and Southeast Asia, serving as a safe and effective modern therapy for Type 2 Diabetes.

Product Overview

This formulation contains Sitagliptin Phosphate, a highly selective Dipeptidyl Peptidase-4 (DPP-4) inhibitor.

The “Smart Sugar” Specialist:

• Glucose-Dependent Action: Unlike Sulfonylureas which squeeze the pancreas regardless of sugar levels, Sitagliptin only stimulates insulin production when blood glucose is high (e.g., after a meal). This drastically reduces the risk of dangerous hypoglycemia (low blood sugar).
• Incretin Enhancer: It blocks the enzyme (DPP-4) that breaks down incretin hormones (GLP-1 and GIP), thereby prolonging their activity to lower blood sugar and suppress glucagon release from the liver.
• Weight Neutral: Does not cause weight gain, making it ideal for obese diabetic patients.
• Beta-Cell Protection: May help preserve the function of pancreatic beta-cells over the long term.

Product Composition & Strength

We supply this product as Film Coated Tablets in Alu-Alu or PVC-PVDC blisters.

*Pack Sizes: Blister packs of 7s, 14s, or 28s (Calendar Packs).

Technical & Logistics Specifications

Critical data for Pharmaceutical Importers and Distributors.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

• Polymorph Stability: Sitagliptin Phosphate is manufactured ensuring the stable crystalline form is maintained during compression and coating.
• Dissolution Profile: Rigorously tested to ensure immediate release characteristics matching the innovator brand (Januvia) for bioequivalence.

Therapeutic Indications (Human Use)

Indicated for the management of Type 2 Diabetes Mellitus:

• Monotherapy: For patients inadequately controlled by diet and exercise alone and for whom Metformin is inappropriate (e.g., due to renal issues).
• Combination Therapy: Frequently prescribed as an add-on to Metformin, Sulfonylureas, Thiazolidinediones, or Insulin when single agents fail to reach HbA1c targets.

Dosage & Administration

Recommended Dosage (Strictly as per Endocrinologist/Physician):

• Route: Oral.
• Standard Adult Dose: 100 mg once daily.
• Renal Impairment:
  • Moderate (CrCl 30–50 mL/min): 50 mg once daily.
  • Severe (CrCl < 30 mL/min): 25 mg once daily.
• Administration: Can be taken with or without food.

Safety Warnings:

• Pancreatitis: Rare reports of acute pancreatitis. Discontinue if severe abdominal pain occurs.
• Hypersensitivity: Rare cases of anaphylaxis, angioedema, or severe skin reactions (Stevens-Johnson syndrome).
• Joint Pain: Severe and disabling joint pain has been reported in some patients taking DPP-4 inhibitors.

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving the needs of international Pharma Traders, Wholesalers, and Bulk Drug Distributors. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for OSD (Oral Solid Dosage) forms, allowing brands to launch high-quality generic medicines under their own label. Whether you are looking for a reliable Hospital Tender Supplier for government procurement in Africa or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely delivery. We actively support Pharmaceutical Drop Shipping models and bulk indenting, ensuring that every Generic Medicine Wholesaler receives WHO-GMP certified products at competitive rates.

Commercial Inquiries

For hospital tenders, bulk export, or distributor pricing, please contact our export team.

WhatsApp/Call: +91 7710003340
Email: info@healthyinc.co.in